CellChat analysis suggested upregulated TGFB signaling in all patient groups toward FBs and myeloid and lymphoid cells and additionally to CMs in Non-COVID-19 or to ECs in Post-Vaccination (Fig. 5e). The gene discussed is TGFB1; the disease is COVID-19.